A p53-p66Shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis

Correlative evidence links stress, accumulation of oxidative cellular damage and ageing in lower organisms and in mammals. We investigated their mechanistic connections in p66Shc knockout mice, which are characterized by increased resistance to oxidative stress and extended life span. We report that...

Full description

Saved in:
Bibliographic Details
Published in:Oncogene Vol. 21; no. 24; pp. 3872 - 3878
Main Authors: TRINEI, Mirella, GIORGIO, Marco, PETRONILLI, Valeria, MINUCCI, Saverio, BERNARDI, Paolo, LANFRANCONE, Luisa, PELICCI, Pier Giuseppe, CICALESE, Angelo, BAROZZI, Sara, VENTURA, Andrea, MIGLIACCIO, Enrica, MILIA, Elisabetta, PADURA, Ines Martin, RAKER, Veronica A, MACCARANA, Marco
Format: Journal Article
Language:English
Published: Basingstoke Nature Publishing 30-05-2002
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Correlative evidence links stress, accumulation of oxidative cellular damage and ageing in lower organisms and in mammals. We investigated their mechanistic connections in p66Shc knockout mice, which are characterized by increased resistance to oxidative stress and extended life span. We report that p66Shc acts as a downstream target of the tumour suppressor p53 and is indispensable for the ability of stress-activated p53 to induce elevation of intracellular oxidants, cytochrome c release and apoptosis. Other functions of p53 are not influenced by p66Shc expression. In basal conditions, p66Shc-/- and p53-/- cells have reduced amounts of intracellular oxidants and oxidation-damaged DNA. We propose that steady-state levels of intracellular oxidants and oxidative damage are genetically determined and regulated by a stress-induced signal transduction pathway involving p53 and p66Shc.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0950-9232
1476-5594
DOI:10.1038/sj.onc.1205513